Clin2
NCT07650851Possibly a fitNot yet recruiting

New oral tablet for itching in dialysis patients

Chronic Kidney Disease-Associated Pruritus in Hemodialysis

Part of Kidney & urinary, Skin clinical trials.

This study tests a new oral medication, nalfurafine hydrochloride, to see if it helps reduce itching in people on dialysis. It might offer a new option for those whose current itch treatments haven't been effective.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You must be between 18 and 80 years old.
  • You must be on regular hemodialysis (3 times a week) for at least 3 months.
  • Your itching must be moderate to severe, with a score of 50 or higher on a 0-100 scale.
  • Your itching must be caused by kidney disease, not by other conditions like allergies or skin infections.
  • You must not have severe heart disease or active cancer, and you must not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07769073Not yet recruiting· Phase 4
Nalfurafine for severe itch in kidney dialysis patients

This study tests a medication called nalfurafine to see if it can reduce severe itching (pruritus) that often comes with advanced kidney disease in people on dialysis. If you have moderate to severe itching and have been on dialysis twice a week for more than 6 months, this trial may offer a potential new treatment option.

NCT07098351Recruiting
A trial for a new itchy skin medicine for people on peritoneal dialysis

This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.

Guangzhou, Guangdong
NCT07380113Recruiting· Phase 4
Comparing two drugs for sleep in dialysis patients with itch

This trial tests if anrikefon or nalfurafine improves sleep quality in people on hemodialysis who have chronic kidney disease-related itching. It aims to find a better treatment for both itch and sleep problems.

Guangzhou, Guangdong
NCT06593392Recruiting· Phase 2
Safety of difelikefalin for itching in teens on dialysis

This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.

Chengdu
NCT07526324Not yet recruiting
Difelikefalin for itching in hemodialysis patients

This trial tests a drug called difelikefalin to see if it can reduce severe itching in people on hemodialysis for chronic kidney disease. If you have troublesome itching despite dialysis, this treatment might help relieve it.

NCT07312916Recruiting
Hand massage for itching in kidney dialysis patients

This study tests whether hand massage can help reduce the chronic itching that many people on dialysis experience. It compares two groups to see if massage provides relief and improves quality of life.

Lausanne, Canton of Vaud

Hear when a new Chronic Kidney Disease-Associated Pruritus in Hemodialysis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.